Results 251 to 260 of about 45,189 (317)
Comparative Effectiveness and Safety of the JAK Inhibitors and Biologic Disease-Modifying Antirheumatic Drugs in Treating Children With Nonsystemic Juvenile Idiopathic Arthritis: A Bayesian Meta-Analysis of Randomized Controlled Trials. [PDF]
Li Y +5 more
europepmc +1 more source
Effectiveness of JAK Inhibitors Compared With Biologic Disease-Modifying Antirheumatic Drugs on Pain Reduction in Rheumatoid Arthritis: Results From a Nationwide Swedish Cohort Study. [PDF]
Eberhard A +10 more
europepmc +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Chirality in antirheumatic drugs
The Lancet, 1991Use of chiral molecules in clinical practice may cause problems because different chiral forms of a drug (enantiomers) may have different biological activities--yet clinicians have little awareness of these risks. After discussion of the chemical conventions used to describe chirality, examples of the influence of chirality on the efficacy and toxicity
W F, Kean, C J, Lock, H E, Howard-Lock
openaire +2 more sources
Disease-modifying antirheumatic drugs
Current Opinion in Rheumatology, 1999Rheumatologists now seem to accept that early treatment of patients with rheumatoid arthritis with disease-modifying antirheumatic drugs is required if erosions are to be prevented. Methotrexate remains the most popular disease-modifying antirheumatic drug and is used in the most popular combination treatments, although the dose needs to be reduced in ...
Ryan, L., Brooks, P. M.
openaire +2 more sources
Disease-modifying antirheumatic drugs
Current Opinion in Rheumatology, 1997The case for early intervention with disease-modifying antirheumatic drugs is strengthened by published reports during the past year. These drugs include methotrexate, gold sulfasalazine, and antimalarial agents. The American College of Rheumatology issued guidelines for the management of rheumatoid arthritis and for monitoring the toxicity of ...
E, Li, P, Brooks, P G, Conaghan
openaire +3 more sources
Drugs, 1975
There are many current concepts of the pathogenesis of rheumatic diseases which incorporate immunological, infectious and hereditary factors. Rheumatic diseases may sometimes become apparent after trauma, be associated with certain diseases and may be induced by nerve damage and serum sickness.
C J, Smyth, J F, Bravo
openaire +2 more sources
There are many current concepts of the pathogenesis of rheumatic diseases which incorporate immunological, infectious and hereditary factors. Rheumatic diseases may sometimes become apparent after trauma, be associated with certain diseases and may be induced by nerve damage and serum sickness.
C J, Smyth, J F, Bravo
openaire +2 more sources
Drugs, 1976
Successful therapy in a chronic rheumatic disease means choosing the right drug for the right patient with the right condition at the right time. In the treatment of gout three different types of treatment are given: for the acute episode, suppression and long-term therapy.
openaire +2 more sources
Successful therapy in a chronic rheumatic disease means choosing the right drug for the right patient with the right condition at the right time. In the treatment of gout three different types of treatment are given: for the acute episode, suppression and long-term therapy.
openaire +2 more sources
Drugs, 1980
With the exception of the treatment of gout and bacterial infections of joints, therapy in the rheumatic diseases remains inadequate. Although many patients gain symptomatic improvement on the drugs currently available, their impact on the underlying disease process remains uncertain.
G L, Craig, W W, Buchanan
openaire +2 more sources
With the exception of the treatment of gout and bacterial infections of joints, therapy in the rheumatic diseases remains inadequate. Although many patients gain symptomatic improvement on the drugs currently available, their impact on the underlying disease process remains uncertain.
G L, Craig, W W, Buchanan
openaire +2 more sources

